Infectious diseases diagnosed – easily and quickly
CEO BluSense Diagnostics
I did my PhD research on the use of Blu-ray players’ optical pick-up unit for biosensing. Our CSO, Marco Donolato, suggested building a marketable biomarker-based blood detection device. Our COO, Robert Burger, brought his expertise in centrifugal microfluidics for assay automation. We landed in Denmark, a favourable environment for medical start-ups.
Translating technology from an R&D project to a diagnostics platform, CE marking and shipping first devices to customers, and contributing to the fight against COVID-19 by developing a serology test. All of these were extremely rewarding moments.
We contribute to the good health and well-being sustainability goal that aims to end neglected tropical diseases by 2030.